LGND operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2026	185,491,500
Mar 31, 2026	169,879,500
Dec 31, 2025	214,300,500
Sep 30, 2025	198,298,000
Jun 30, 2025	198,762,000
Mar 31, 2025	238,443,000
Dec 31, 2024	178,665,000
Sep 30, 2024	158,848,000
Jun 30, 2024	148,979,000
Mar 31, 2024	99,702,000
Dec 31, 2023	108,837,000
Sep 30, 2023	72,297,000
Jun 30, 2023	78,719,000
Mar 31, 2023	81,142,000
Dec 31, 2022	84,769,000
Sep 30, 2022	139,269,000
Jun 30, 2022	144,225,000
Mar 31, 2022	123,465,000
Dec 31, 2021	136,063,000
Sep 30, 2021	135,349,000
Jun 30, 2021	129,414,000
Mar 31, 2021	147,747,000
Dec 31, 2020	130,155,000
Sep 30, 2020	118,359,000
Jun 30, 2020	113,430,000
Mar 31, 2020	113,466,000
Dec 31, 2019	114,656,000
Sep 30, 2019	102,897,000
Jun 30, 2019	96,919,000
Mar 31, 2019	88,941,000
Dec 31, 2018	81,389,000
Sep 30, 2018	78,279,000
Jun 30, 2018	71,935,000
Mar 31, 2018	67,278,000
Dec 31, 2017	67,660,000
Sep 30, 2017	63,049,000
Jun 30, 2017	63,461,000
Mar 31, 2017	63,435,000
Dec 31, 2016	58,078,000
Sep 30, 2016	51,371,000
Jun 30, 2016	43,971,000
Mar 31, 2016	41,155,000
Dec 31, 2015	37,758,000
Sep 30, 2015	37,497,000
Jun 30, 2015	39,751,000
Mar 31, 2015	36,444,000
Dec 31, 2014	34,691,000
Sep 30, 2014	32,688,000
Jun 30, 2014	30,095,000
Mar 31, 2014	28,495,000
Dec 31, 2013	27,259,000
Sep 30, 2013	27,224,000
Jun 30, 2013	27,083,000
Mar 31, 2013	27,545,000
Dec 31, 2012	26,898,000
Sep 30, 2012	27,013,000
Jun 30, 2012	26,139,000
Mar 31, 2012	26,441,000
Dec 31, 2011	26,287,000
Sep 30, 2011	28,263,000
Jun 30, 2011	45,585,000
Mar 31, 2011	47,959,000
Dec 31, 2010	52,203,000
Sep 30, 2010	71,735,000
Jun 30, 2010	60,594,000
Mar 31, 2010	63,429,000
Dec 31, 2009	70,298,000
Sep 30, 2009	55,694,000
Jun 30, 2009	54,961,000
Mar 31, 2009	53,097,000
Dec 31, 2008	52,591,000
Sep 30, 2008	52,625,000
Jun 30, 2008	55,225,000
Mar 31, 2008	60,564,000
Dec 31, 2007	73,069,000
Sep 30, 2007	82,619,000
Jun 30, 2007	114,388,000
Mar 31, 2007	147,783,000
Dec 31, 2006	296,822,000
Sep 30, 2006	314,899,000
Jun 30, 2006	305,219,000
Mar 31, 2006	297,687,000
Dec 31, 2005	161,060,000
Sep 30, 2005	158,475,000
Jun 30, 2005	164,554,000
Mar 31, 2005	164,714,000
Dec 31, 2004	161,079,000
Sep 30, 2004	160,516,000
Jun 30, 2004	149,057,000
Mar 31, 2004	137,688,000
Dec 31, 2003	128,699,000
Sep 30, 2003	117,754,000
Jun 30, 2003	113,249,000
Mar 31, 2003	106,779,000
Dec 31, 2002	100,486,000
Sep 30, 2002	93,944,000
Jun 30, 2002	87,625,000
Mar 31, 2002	86,679,000
Dec 31, 2001	87,404,000
Sep 30, 2001	81,980,000